Literature DB >> 30059145

Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches.

Yingying Guo1, Xiaoyan Chu2, Neil J Parrott3, Kim L R Brouwer4, Vicky Hsu5, Swati Nagar6, Pär Matsson7, Pradeep Sharma8, Jan Snoeys9, Yuichi Sugiyama10, Daniel Tatosian2, Jashvant D Unadkat11, Shiew-Mei Huang5, Aleksandra Galetin12.   

Abstract

This white paper examines recent progress, applications, and challenges in predicting unbound and total tissue and intra/subcellular drug concentrations using in vitro and preclinical models, imaging techniques, and physiologically based pharmacokinetic (PBPK) modeling. Published examples, regulatory submissions, and case studies illustrate the application of different types of data in drug development to support modeling and decision making for compounds with transporter-mediated disposition, and likely disconnects between tissue and systemic drug exposure. The goals of this article are to illustrate current best practices and outline practical strategies for selecting appropriate in vitro and in vivo experimental methods to estimate or predict tissue and plasma concentrations, and to use these data in the application of PBPK modeling for human pharmacokinetic (PK), efficacy, and safety assessment in drug development.
© 2018 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30059145      PMCID: PMC6197917          DOI: 10.1002/cpt.1183

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  107 in total

1.  Quantitative modeling of selective lysosomal targeting for drug design.

Authors:  Stefan Trapp; Gus R Rosania; Richard W Horobin; Johannes Kornhuber
Journal:  Eur Biophys J       Date:  2008-05-27       Impact factor: 1.733

2.  Toward a unified model of passive drug permeation II: the physiochemical determinants of unbound tissue distribution with applications to the design of hepatoselective glucokinase activators.

Authors:  Avijit Ghosh; Tristan S Maurer; John Litchfield; Manthema V Varma; Charles Rotter; Renato Scialis; Bo Feng; Meihua Tu; Cris R W Guimaraes; Dennis O Scott
Journal:  Drug Metab Dispos       Date:  2014-07-14       Impact factor: 3.922

Review 3.  Physiologically based pharmacokinetic modeling in drug discovery and development: a pharmaceutical industry perspective.

Authors:  H M Jones; Y Chen; C Gibson; T Heimbach; N Parrott; S A Peters; J Snoeys; V V Upreti; M Zheng; S D Hall
Journal:  Clin Pharmacol Ther       Date:  2015-01-09       Impact factor: 6.875

Review 4.  Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions.

Authors:  Oliver Langer
Journal:  J Clin Pharmacol       Date:  2016-07       Impact factor: 3.126

5.  Possible Role of Organic Cation Transporters in the Distribution of [11C]Sulpiride, a Dopamine D2 Receptor Antagonist.

Authors:  Harumasa Takano; Sumito Ito; Xuan Zhang; Hiroshi Ito; Ming-Rong Zhang; Hiroshi Suzuki; Kazuya Maeda; Hiroyuki Kusuhara; Tetsuya Suhara; Yuichi Sugiyama
Journal:  J Pharm Sci       Date:  2017-05-10       Impact factor: 3.534

6.  Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.

Authors:  Sumathy Mathialagan; Mary A Piotrowski; David A Tess; Bo Feng; John Litchfield; Manthena V Varma
Journal:  Drug Metab Dispos       Date:  2017-02-08       Impact factor: 3.922

7.  PET imaging-based evaluation of hepatobiliary transport in humans with (15R)-11C-TIC-Me.

Authors:  Tadayuki Takashima; Satoshi Kitamura; Yasuhiro Wada; Masaaki Tanaka; Yoshihito Shigihara; Hideki Ishii; Ryosuke Ijuin; Susumu Shiomi; Takahiro Nakae; Yumiko Watanabe; Yilong Cui; Hisashi Doi; Masaaki Suzuki; Kazuya Maeda; Hiroyuki Kusuhara; Yuichi Sugiyama; Yasuyoshi Watanabe
Journal:  J Nucl Med       Date:  2012-04-12       Impact factor: 10.057

8.  Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics.

Authors:  Li Wang; Carol Collins; Edward J Kelly; Xiaoyan Chu; Adrian S Ray; Laurent Salphati; Guangqing Xiao; Caroline Lee; Yurong Lai; Mingxiang Liao; Anita Mathias; Raymond Evers; William Humphreys; Cornelis E C A Hop; Sean C Kumer; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2016-08-19       Impact factor: 3.922

9.  Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.

Authors:  Anand K Deo; Soo Borson; Jeanne M Link; Karen Domino; Janet F Eary; Ban Ke; Todd L Richards; David A Mankoff; Satoshi Minoshima; Finbarr O'Sullivan; Sara Eyal; Peng Hsiao; Ken Maravilla; Jashvant D Unadkat
Journal:  J Nucl Med       Date:  2014-05-19       Impact factor: 11.082

10.  Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5.

Authors:  K Yoshida; B Sun; L Zhang; P Zhao; D R Abernethy; T D Nolin; A Rostami-Hodjegan; I Zineh; S-M Huang
Journal:  Clin Pharmacol Ther       Date:  2016-03-07       Impact factor: 6.875

View more
  30 in total

Review 1.  Drug Concentration Asymmetry in Tissues and Plasma for Small Molecule-Related Therapeutic Modalities.

Authors:  Donglu Zhang; Cornelis E C A Hop; Gabriela Patilea-Vrana; Gautham Gampa; Herana Kamal Seneviratne; Jashvant D Unadkat; Jane R Kenny; Karthik Nagapudi; Li Di; Lian Zhou; Mark Zak; Matthew R Wright; Namandjé N Bumpus; Richard Zang; Xingrong Liu; Yurong Lai; S Cyrus Khojasteh
Journal:  Drug Metab Dispos       Date:  2019-07-02       Impact factor: 3.922

2.  Positron Emission Tomography Imaging of [11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A.

Authors:  Sarah Billington; Steven Shoner; Scott Lee; Kindra Clark-Snustad; Matthew Pennington; David Lewis; Mark Muzi; Shirley Rene; Jean Lee; Tot Bui Nguyen; Vineet Kumar; Kazuya Ishida; Laigao Chen; Xiaoyan Chu; Yurong Lai; Laurent Salphati; Cornelis E C A Hop; Guangqing Xiao; Mingxiang Liao; Jashvant D Unadkat
Journal:  Clin Pharmacol Ther       Date:  2019-07-22       Impact factor: 6.875

3.  Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades.

Authors:  Lei Zhang; Qi Liu; Shiew-Mei Huang; Robert Lionberger
Journal:  Drug Metab Dispos       Date:  2022-06-29       Impact factor: 3.579

Review 4.  Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.

Authors:  Kit Wun Kathy Cheung; Bianca D van Groen; Gilbert J Burckart; Lei Zhang; Saskia N de Wildt; Shiew-Mei Huang
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

Review 5.  Potential implications of DMET ontogeny on the disposition of commonly prescribed drugs in neonatal and pediatric intensive care units.

Authors:  Siavosh Naji-Talakar; Sheena Sharma; Leslie A Martin; Derek Barnhart; Bhagwat Prasad
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-01-20       Impact factor: 4.481

6.  Brain Distribution of Drugs: Pharmacokinetic Considerations.

Authors:  Irena Loryan; Margareta Hammarlund-Udenaes; Stina Syvänen
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.

Authors:  Amais Ahmad; Kayode Ogungbenro; Annett Kunze; Frank Jacobs; Jan Snoeys; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-05-01

8.  Hybrid physiologically-based pharmacokinetic model for remdesivir: Application to SARS-CoV-2.

Authors:  James M Gallo
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689

9.  Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices.

Authors:  Ondrej Martinec; Carin Biel; Inge A M de Graaf; Martin Huliciak; Koert P de Jong; Frantisek Staud; Filip Cecka; Peter Olinga; Ivan Vokral; Lukas Cerveny
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

10.  Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation.

Authors:  Md Masud Parvez; Abdul Basit; Parth B Jariwala; Zsuzsanna Gáborik; Emese Kis; Scott Heyward; Matthew R Redinbo; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2021-06-01       Impact factor: 3.579

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.